SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings ($CLIK) is trending due to significant revenue growth and its micro-float status, drawing attention from traders seeking potential for substantial gains. Community members highlight the stock's small float and revenue increase, anticipating a potential breakout. Some are attributing the recent price action to a bot alert and solid news, while also comparing it to other low-float runners.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending due to community discussion around an Adweek article and its potential impact from Amazon's competitive moves in the DSP space, with many suggesting the article was misleading and reporting it to the SEC. Community members are debating the long-term value of TTD amidst competition from larger tech companies and potential market manipulation. Despite concerns, some bulls remain confident in the stock's potential, citing strong fundamentals and potential for a rebound.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as retail traders discuss a potential short squeeze, with community members pointing to high borrowing costs for short sellers and a limited float. Talk centers around a large buy order that could trigger significant upward movement. Some traders are comfortable holding shares while others are looking for an entry point or taking profits.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending due to an upcoming FDA decision on their drug Revuforj for a specific type of leukemia, with the community actively discussing the potential market impact and likelihood of approval. While some express concerns about potential side effects and a history of sell-offs post-approval, others point to the drug's efficacy and the company's strong financial position, anticipating a significant upside if approved. Community members are closely monitoring discussions around analyst price targets, short interest, and potential buyout scenarios.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending due to after-hours price action and community speculation about a potential short squeeze or upcoming news, despite the company stating they are unaware of any material changes. Traders are actively discussing potential price movements and the possibility of dilution, creating volatility. The stock's movement is also attracting attention as a potential play in the medical sector.

Meet DragonWifBeard: The world's first AI-powered pet dragon!  More Than Just Scales: DragonWifBeard is a real-life bearded dragon revolutionizing the pet experience. He's not just any reptile – he's equipped with cutting-edge Eliza AI agent, giving him a unique personality and the ability to interact with his environment in unprecedented ways. The Future of Companionship: This groundbreaking project merges the love for pets with the limitless possibilities of AI. Witness the dawn of a new era in companionship with DragonWithBeard.

DragonWifBeard

DragonWifBeard ($DWB) is trending as community members highlight its potential for 'fire' and 'profits,' inviting others to join. Conversations frequently mention Solana ($SOL) and other popular cryptos, with users emphasizing the token's availability on Phantom Wallet. The discussions suggest a focus on community growth and capitalizing on the token's momentum.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid community discussion around a recent FDA investigation into allergic reactions linked to specific lots of intravenous immune globulin (IVIG) drugs, including two ADMA products; although these reactions are acknowledged as rare, the news has sparked concerns and trading volatility. Some investors view the dip as a buying opportunity, citing the company's strong fundamentals and potential for a pre-earnings run, while others express frustration with the stock's recent performance and management's silence.

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Genenta Science SpA - ADR

GNTA is experiencing significant volatility, with community members actively discussing a large pre-market surge following news of a strategic partnership. The conversation includes speculation about a short squeeze, potential for further gains, and caution due to the stock's history of volatile price action and possible pump and dump schemes. Some traders are taking profits while others are holding in anticipation of after-hours movement.

U.S. Gold Corp. engages in the exploration of gold properties. It has properties in CK Gold Project, Wyoming, Challis Gold Project, Idaho, and Keystone, Nevada. The company was founded in 1967 and is headquartered in Elko, NV.

U.S. Gold Corp

U.S. Gold Corp ($USAU) is trending as investors discuss its potential spin-off of the Keystone project and debt financing options expected by year-end. Bullish sentiment is fueled by rising gold prices and upcoming Russell index inclusion, while some community members express concerns about management experience and potential dilution. Discussions also involve price targets and speculation about institutional accumulation.

MaxsMaking, Inc. is a holding company, which engages in the manufacture of customized consumer goods. It offers a range of customizable textile products, including backpacks, thermal bags, canvas bags, aprons, throw pillows, flags, and advertising chair covers. The company was founded by Xiao Zhong Lin and Xue Fen Zhang in January 2007 and is headquartered in Shanghai, China.

MaxsMaking Inc. - Ordinary Shares - Class A

MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc. is trending due to discussions around its low float and potential for significant price movement, with some traders comparing it to other recent runners. Community members are actively speculating about short squeezes and potential for high volatility, while also noting the company's textile manufacturing business in China.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharnext SA develops and manufactures drugs for neurological diseases. Its products include R&D Pipeline, PXT3003, and PXT864 are used for the treatment of Charcot-Marie-Tooth disease, diabetic, and toxic peripheral neuropathies, as well as severe neurodegenerative diseases in general and peripheral neuropathies. The company was founded in 2007 by Daniel Cohen, Loic Heidsieck, Serguei Nabirotchkine, Oxana Guerassimenko and Ilya Chumakov and is headquartered in Paris, France.

Pharnext

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$25,000.00
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	$25,000.00
Beta	0.00
Avg. Volume	0.00
PE Ratio	N/A

52-Week High	$25,000.00
52-Week Low	$25,000.00
Market Capitalization	$1,190.00
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

PNEXD
Pharnext

Feed

News

Sentiment

Fundamentals

Info

Latest PNEXD News

PNEXDPharnext